The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
發表在: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
VerfasserIn: | Unterberg, Matthias (VerfasserIn), Rahmel, Tim (VerfasserIn), Köhler, Thomas (VerfasserIn), Henzler, Dietrich (VerfasserIn), Schwier, Elke (VerfasserIn) |
格式: | Aufsatz in Zeitschrift |
語言: | English |
出版: |
2022
|
主題: | |
在線閱讀: | https://doi.org/10.1186/s12871-021-01547-8 |
相關項目: | In:
BMC Anesthesiology |
相似書籍
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
由: Kirchner, Carmen, et al.
出版: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
由: Köhler, Thomas, et al.
出版: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
由: Grautoff, Steffen
出版: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
由: Köhler, Thomas, et al.
出版: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
由: Schwier, Elke, et al.
出版: (2021)